Asia Pacific Congestive Heart Failure Treatment Devices Market Size & Outlook
Asia Pacific congestive heart failure treatment devices market, 2018-2030 (US$M)
Related Markets
Asia Pacific congestive heart failure treatment devices market highlights
- The Asia Pacific congestive heart failure treatment devices market generated a revenue of USD 6,801.5 million in 2023.
- The market is expected to grow at a CAGR of 8.6% from 2024 to 2030.
- In terms of segment, ventricular assist devices was the largest revenue generating product in 2023.
- Ventricular assist devices is the most lucrative product segment registering the fastest growth during the forecast period.
Asia Pacific data book summary
| Market revenue in 2023 | USD 6,801.5 million |
| Market revenue in 2030 | USD 12,119.7 million |
| Growth rate | 8.6% (CAGR from 2023 to 2030) |
| Largest segment | Ventricular assist devices |
| Fastest growing segment | Ventricular assist devices |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Ventricular assist devices |
| Key market players worldwide | Medtronic PLC, Boston Scientific Corp, BIOTRONIK, Abbott Laboratories |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 24.4% of the global congestive heart failure treatment devices market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- MEA is the fastest growing regional market and is projected to reach USD 2,350.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Congestive Heart Failure Treatment Devices Market Scope
Congestive Heart Failure Treatment Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific congestive heart failure treatment devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to congestive heart failure treatment devices market will help companies and investors design strategic landscapes.
Ventricular assist devices was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Asia Pacific congestive heart failure treatment devices market based on ventricular assist devices covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to the improving healthcare infrastructure with government endeavors. Moreover, economic development in countries, such as India and China, are expected to support market growth.
The huge population base with a low per capita income in Asia Pacific has led to a high demand for affordable treatment options. Multinational companies are looking forward to investing in developing countries including India and China. Thus, several collaborative partnerships and strategic alliances are taking place amongst the companies in this region.
Reasons to subscribe to Asia Pacific congestive heart failure treatment devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific congestive heart failure treatment devices market databook
-
Our clientele includes a mix of congestive heart failure treatment devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific congestive heart failure treatment devices market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific congestive heart failure treatment devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific congestive heart failure treatment devices market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
